Humana Inc. (0J6Z.L)
USD 257.72
(-0.95%)
USD 257.72
(-0.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 106.44 Billion USD | 14.61% |
| 2022 | 92.87 Billion USD | 10.31% |
| 2021 | 84.19 Billion USD | 9.12% |
| 2020 | 77.15 Billion USD | 18.9% |
| 2019 | 64.88 Billion USD | 14.01% |
| 2018 | 56.91 Billion USD | 5.85% |
| 2017 | 53.76 Billion USD | -1.13% |
| 2016 | 54.37 Billion USD | 0.17% |
| 2015 | 54.28 Billion USD | 11.94% |
| 2014 | 48.5 Billion USD | 17.4% |
| 2013 | 41.31 Billion USD | 5.59% |
| 2012 | 39.12 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 29.39 Billion USD | -0.48% |
| 2024 Q1 | 29.61 Billion USD | 11.9% |
| 2024 Q2 | 29.54 Billion USD | -0.24% |
| 2023 Q2 | 26.74 Billion USD | 0.02% |
| 2023 Q1 | 26.74 Billion USD | 19.18% |
| 2023 FY | 106.44 Billion USD | 14.61% |
| 2023 Q3 | 26.42 Billion USD | -1.21% |
| 2023 Q4 | 26.46 Billion USD | 0.15% |
| 2022 Q4 | 22.43 Billion USD | -1.58% |
| 2022 Q2 | 23.66 Billion USD | -1.28% |
| 2022 Q1 | 23.97 Billion USD | 13.85% |
| 2022 FY | 92.87 Billion USD | 10.31% |
| 2022 Q3 | 22.79 Billion USD | -3.65% |
| 2021 Q2 | 20.64 Billion USD | -0.11% |
| 2021 Q4 | 21.05 Billion USD | -3.54% |
| 2021 FY | 84.19 Billion USD | 9.12% |
| 2021 Q1 | 20.66 Billion USD | 8.43% |
| 2021 Q3 | 21.82 Billion USD | 5.72% |
| 2020 Q1 | 18.93 Billion USD | 16.2% |
| 2020 Q3 | 20.07 Billion USD | 5.2% |
| 2020 Q4 | 19.06 Billion USD | -5.05% |
| 2020 FY | 77.15 Billion USD | 18.9% |
| 2020 Q2 | 19.08 Billion USD | 0.78% |
| 2019 FY | 64.88 Billion USD | 14.01% |
| 2019 Q4 | 16.29 Billion USD | 0.33% |
| 2019 Q3 | 16.24 Billion USD | -0.02% |
| 2019 Q2 | 16.24 Billion USD | 0.86% |
| 2019 Q1 | 16.1 Billion USD | 13.69% |
| 2018 Q4 | 14.16 Billion USD | -0.27% |
| 2018 Q2 | 14.25 Billion USD | -0.14% |
| 2018 FY | 56.91 Billion USD | 5.85% |
| 2018 Q1 | 14.27 Billion USD | 8.26% |
| 2018 Q3 | 14.2 Billion USD | -0.37% |
| 2017 FY | 53.76 Billion USD | -1.13% |
| 2017 Q3 | 13.28 Billion USD | -1.86% |
| 2017 Q1 | 13.76 Billion USD | 6.86% |
| 2017 Q4 | 13.18 Billion USD | -0.7% |
| 2017 Q2 | 13.53 Billion USD | -1.66% |
| 2016 Q3 | 13.69 Billion USD | -2.23% |
| 2016 FY | 54.37 Billion USD | 0.17% |
| 2016 Q4 | 12.87 Billion USD | -5.96% |
| 2016 Q2 | 14 Billion USD | 1.5% |
| 2016 Q1 | 13.8 Billion USD | 3.29% |
| 2015 Q1 | 13.83 Billion USD | 12.21% |
| 2015 FY | 54.28 Billion USD | 11.94% |
| 2015 Q4 | 13.36 Billion USD | -0.01% |
| 2015 Q3 | 13.36 Billion USD | -2.69% |
| 2015 Q2 | 13.73 Billion USD | -0.73% |
| 2014 Q4 | 12.32 Billion USD | 0.74% |
| 2014 Q2 | 12.22 Billion USD | 4.35% |
| 2014 FY | 48.5 Billion USD | 17.4% |
| 2014 Q1 | 11.71 Billion USD | 14.97% |
| 2014 Q3 | 12.23 Billion USD | 0.13% |
| 2013 Q1 | 10.48 Billion USD | 9.72% |
| 2013 Q2 | 10.32 Billion USD | -1.57% |
| 2013 Q3 | 10.31 Billion USD | -0.02% |
| 2013 Q4 | 10.18 Billion USD | -1.28% |
| 2013 FY | 41.31 Billion USD | 5.59% |
| 2012 Q3 | 9.65 Billion USD | -0.49% |
| 2012 FY | 39.12 Billion USD | 0.0% |
| 2012 Q2 | 9.69 Billion USD | 0.0% |
| 2012 Q4 | 9.55 Billion USD | -0.97% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -52659.672% |
| Accuray Incorporated | 143.12 Million USD | -74270.637% |
| Align Technology, Inc. | 2.72 Billion USD | -3813.001% |
| Elevance Health Inc. | 47.01 Billion USD | -126.42% |
| AxoGen, Inc. | 127.87 Million USD | -83138.188% |
| Boston Scientific Corporation | 9.84 Billion USD | -980.719% |
| CVS Health Corporation | 54.43 Billion USD | -95.55% |
| Cardinal Health, Inc. | 7.41 Billion USD | -1335.662% |
| Centene Corporation | 153.99 Billion USD | 30.883% |
| DaVita Inc. | 3.82 Billion USD | -2686.074% |
| HCA Healthcare, Inc. | 55.06 Billion USD | -93.295% |
| Hologic, Inc. | 2.23 Billion USD | -4656.457% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -4760.341% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -3063.244% |
| Masimo Corporation | 1 Billion USD | -10506.876% |
| McKesson Corporation | 12.58 Billion USD | -745.836% |
| Patterson Companies, Inc. | 1.38 Billion USD | -7611.691% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -3494.732% |
| ResMed Inc. | 2.6 Billion USD | -3980.065% |
| Henry Schein, Inc. | 3.65 Billion USD | -2815.366% |
| Teladoc Health, Inc. | 1.84 Billion USD | -5677.297% |
| Universal Health Services, Inc. | 1.17 Billion USD | -8955.787% |
| Veeva Systems Inc. | 1.68 Billion USD | -6211.737% |
| Baxter International Inc. | 4.97 Billion USD | -2039.497% |
| Becton, Dickinson and Company | 8.82 Billion USD | -1106.392% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -2150.555% |
| Danaher Corporation | 14.12 Billion USD | -653.344% |
| Stryker Corporation | 13.05 Billion USD | -715.132% |
| Medtronic plc | 21.27 Billion USD | -400.353% |